Robinhood (HOOD) is rated a long-term buy after Q3 growth, new products, and stock pullback. Read here for latest insights.

Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.

Dietitians are not just end-users of AI tools. They can be cocreators, leaders, and subject matter experts on AI projects. In ...

What are stereotypes about Nigerians? Discover the truth behind harmful stereotypes, Nigeria's economic impact & how ...

Segway Powersports, a global innovator in intelligent off-road vehicles and connected riding systems, recently introduced the AT10 W MUD at EICMA 2025 in Milan. The new ATV is purpose-built for deep ...

The Global Hyaluronic Acid Based Dermal Fillers Market Size projected to grow at a CAGR of 4.03% from 2024 to 2031, according to a new ...

For more information, visit Berlin, Germany, Nov. 14, 2025 (GLOBE NEWSWIRE) -- think-cell proudly announces the launch of a ...

Apellis Pharmaceuticals recently announced post hoc analysis data of the GALE extension study. This new data is the result of ...

Thank you, Paul. The continued momentum in both our U.S. and international businesses during Q3 saw over 14 million average ...

Late Thursday, New York-based Warburg announced an agreement to buy ECN, run by entrepreneur and chief executive officer ...

The Cardiac Arrest Treatment Market is witnessing substantial growth due to the increasing prevalence of cardiovascular diseases, rising awareness about emergency cardiac care, and advancements in ...